Both in Pharmaceuticals
Vanda Pharmaceuticals vs Standard BioTools
Over the past year VNDA returned −15.2% and LAB returned −50.8%; their daily moves had a correlation of 0.07.
VNDA −15.2% LAB −50.8%Growth of $1, one year, split-adjusted
| Metric | VNDA | LAB |
|---|---|---|
| Price | $3.79 | $0.6100 |
| Market cap | $229.2M | $240.8M |
| Today | −6.42% | −1.61% |
| 1 month | −21.2% | −16.2% |
| 6 months | −45.9% | −34.8% |
| Year to date | −57.0% | −52.3% |
| 1 year | −29.9% | −48.7% |
| Revenue growth (YoY) | +24.1% | −7.6% |
| Gross margin | 94.1% | 52.4% |
| Net margin | −32.3% | −133.1% |
| P/E (TTM) | — | 2.8× |
| Price / sales | 1.0× | 2.8× |
| Net cash | $138.1M | $476.4M |
| Dividend yield | — | — |
| Volatility (60d) | 38.3% | 45.5% |
| Short % of float | 15.4% | 1.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).